Advanced Unresectable or Metastatic Solid Malignancy

1 clinical trials · Condition

Record	Firm	Date
A Study Evaluating Targeted Therapies in Participants Who Have Advanced Solid Tumors With Genomic Alterations or Protein Expression Patterns Predictive of Response (NCT04632992)	Genentech, Inc.	2021-01-13

Every clearance here is in the API, with alerts when new ones post.